76 related articles for article (PubMed ID: 2209670)
21. [3H]GBR-12935 binding to cytochrome P450 in the human brain.
Allard P; Marcusson JO; Ross SB
J Neurochem; 1994 Jan; 62(1):342-8. PubMed ID: 8263534
[TBL] [Abstract][Full Text] [Related]
22. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.
Dewar KM; Reader TA
Synapse; 1989; 4(4):378-86. PubMed ID: 2532424
[TBL] [Abstract][Full Text] [Related]
23. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
24. [3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia.
Czudek C; Reynolds GP
J Neural Transm; 1989; 77(2-3):227-30. PubMed ID: 2760605
[TBL] [Abstract][Full Text] [Related]
25. Neurotransmitters in dementia.
Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
[TBL] [Abstract][Full Text] [Related]
26. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
27. Reduced number of caudate nucleus dopamine uptake sites in vascular dementia.
Allard P; Englund E; Marcusson J
Dement Geriatr Cogn Disord; 1999; 10(2):77-80. PubMed ID: 10026379
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
29. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Toide K; Unemi N; Segawa T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
[TBL] [Abstract][Full Text] [Related]
30. Studies on neurotransmitter binding in senile dementia. Comparison of Alzheimer's and mixed vascular-Alzheimer's dementias.
Jenni-Eiermann S; von Hahn HP; Honegger CG; Ulrich J
Gerontology; 1984; 30(6):350-8. PubMed ID: 6151534
[TBL] [Abstract][Full Text] [Related]
31. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.
Sasaki H; Muramoto O; Kanazawa I; Arai H; Kosaka K; Iizuka R
Ann Neurol; 1986 Mar; 19(3):263-9. PubMed ID: 2870679
[TBL] [Abstract][Full Text] [Related]
32. Striatal dopamine receptors in Alzheimer-type dementia.
Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Markakis D
Neurosci Lett; 1984 Nov; 52(1-2):1-6. PubMed ID: 6241300
[TBL] [Abstract][Full Text] [Related]
33. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
34. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
Reinikainen KJ; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen PJ
J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858
[TBL] [Abstract][Full Text] [Related]
35. Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms.
Bierer LM; Knott PJ; Schmeidler JM; Marin DB; Ryan TM; Haroutunian V; Purohit DP; Perl DP; Mohs RC; Davis KL
Psychiatry Res; 1993 Dec; 49(3):211-7. PubMed ID: 8177917
[TBL] [Abstract][Full Text] [Related]
36. [A follow-up study on the outcome and relevant factors in senile dementia of Alzheimer type and vascular dementia].
Ueki A; Shinjo H; Nakajima T; Miwa C; Morita Y
Nihon Ronen Igakkai Zasshi; 1999 May; 36(5):358-64. PubMed ID: 10466354
[TBL] [Abstract][Full Text] [Related]
37. Changes in the brain catecholamines in patients with dementia of Alzheimer type.
Adolfsson R; Gottfries CG; Roos BE; Winblad B
Br J Psychiatry; 1979 Sep; 135():216-23. PubMed ID: 486847
[TBL] [Abstract][Full Text] [Related]
38. Quantitative autoradiographic localization of the dopamine transport complex in the rat brain: use of a highly selective radioligand: [3H]GBR 12935.
Dawson TM; Gehlert DR; Wamsley JK
Eur J Pharmacol; 1986 Jul; 126(1-2):171-3. PubMed ID: 3758162
[No Abstract] [Full Text] [Related]
39. Clinical and positron emission tomographic studies in the 'extrapyramidal syndrome' of dementia of the Alzheimer type.
Tyrrell PJ; Sawle GV; Ibanez V; Bloomfield PM; Leenders KL; Frackowiak RS; Rossor MN
Arch Neurol; 1990 Dec; 47(12):1318-23. PubMed ID: 2252449
[TBL] [Abstract][Full Text] [Related]
40. Reduction in number of dopamine uptake sites but unchanged number of piperazine-acceptor/CYP450IID6 binding sites in the human caudate nucleus in aging.
Norlén M; Allard P
Neurosci Lett; 1996 May; 209(3):161-4. PubMed ID: 8736635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
